Form 4: Privia Health Director David Wichmann Receives Restricted Stock Units

Privia Health Group, Inc. Director David S. Wichmann was granted 8,396 restricted stock units on May 21, 2025, increasing his direct beneficial ownership.

Summary

• David S. Wichmann, a Director of Privia Health Group, Inc. (PRVA), acquired 8,396 shares of Common Stock in the form of restricted stock units (RSUs).
• The transaction occurred on May 21, 2025.
• These RSUs were granted under the Issuer's 2021 Omnibus Incentive Plan.
• The restricted stock units will vest on the earlier of (i) the day immediately preceding the Company's 2026 annual meeting of stockholders and (ii) the first anniversary of the grant date (May 21, 2026).
• Following this transaction, Mr. Wichmann directly beneficially owns 25,709 shares of Common Stock.
• He also indirectly beneficially owns 1,315,340 shares through Jory Capital, LLC, which he co-owns.

Sentiment

Score: 6

Explanation: The sentiment is mildly positive as it indicates ongoing director compensation and alignment of interests, but it's a routine filing with no significant new strategic or financial information.

Positives

• The grant of restricted stock units aligns the director's interests with those of shareholders, as the value of the units is tied to the company's stock performance.
• The grant is part of the Issuer's 2021 Omnibus Incentive Plan, indicating a structured approach to executive compensation and retention.

Risks

• The value of the restricted stock units is subject to the future performance of Privia Health Group, Inc.'s common stock.

Future Outlook

The restricted stock units granted to Director David S. Wichmann are scheduled to vest on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or the first anniversary of the grant date (May 21, 2026).

Industry Context

This filing represents a routine insider transaction, common across industries, where directors receive equity compensation to align their interests with shareholders. It does not provide broader industry trends or competitive analysis.

Corporate Governance

Related Party Transactions

• David S. Wichmann indirectly beneficially owns 1,315,340 shares through Jory Capital, LLC, which is co-owned by the Reporting Person.

Stakeholder Impact

• Shareholders: The grant of RSUs to a director aligns management incentives with shareholder interests, potentially fostering long-term value creation.

Next Steps

• Vesting of the restricted stock units on the earlier of the day immediately preceding the Company's 2026 annual meeting of stockholders or May 21, 2026.

Key Dates

Recommendation

Keywords

Privia Health Group, PRVA, Form 4, Restricted Stock Units, RSU, Insider Transaction, Director Compensation, Equity Grant, David S. Wichmann